ACIP Panel Votes to Scrap Universal Hepatitis B Shot, Drawing Fire from Critics Warning Infection Spikes
The Advisory Committee on Immunization Practices (ACIP) suggested abandoning the routine, universal hepatitis B vaccine recommendation for all newborns, potentially delaying the first dose until a baby is at least two months old in some cases.
People are divided between the proposed shift and established doctrine. Some points, attributed to forum users, favor 'shared clinical decision-making' for babies whose mothers test negative. Conversely, critics warn loudly that this reversal could cause a significant rise in chronic infections among children. The established CDC recommendation, however, insists every baby receives the shot within 24 hours, regardless of maternal status.
The weight of the visible arguments shows a direct clash: the proposed localized decision-making clashes head-on with the 34-year federal standard. Critics are openly predicting a major public health dip based on the ACIP's committee vote.
Key Points
#1ACIP committee moved to change vaccine timing based on mother's test results.
The committee signaled a move away from the universal recommendation, favoring 'shared clinical decision-making' for specific cases.
#2Established CDC protocol remains in place.
The CDC still recommends the vaccine for every baby within 24 hours of birth, ignoring maternal status.
#3Critics predict a severe public health failure.
Warning voices claim the policy change could trigger an increase in chronic, incurable hepatitis B infections among children.
#4The existing structure mandates follow-up doses.
The proposed change only alters the timing of the *first* shot; subsequent doses remain scheduled for 2 months and 6-18 months.
Source Discussions (3)
This report was synthesized from the following Lemmy discussions, ranked by community score.